Correlation Between Groupe Sfpi and Maat Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Groupe Sfpi and Maat Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Groupe Sfpi and Maat Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Groupe Sfpi and Maat Pharma SA, you can compare the effects of market volatilities on Groupe Sfpi and Maat Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Groupe Sfpi with a short position of Maat Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Groupe Sfpi and Maat Pharma.

Diversification Opportunities for Groupe Sfpi and Maat Pharma

-0.7
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Groupe and Maat is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Groupe Sfpi and Maat Pharma SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maat Pharma SA and Groupe Sfpi is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Groupe Sfpi are associated (or correlated) with Maat Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maat Pharma SA has no effect on the direction of Groupe Sfpi i.e., Groupe Sfpi and Maat Pharma go up and down completely randomly.

Pair Corralation between Groupe Sfpi and Maat Pharma

Assuming the 90 days trading horizon Groupe Sfpi is expected to generate 0.48 times more return on investment than Maat Pharma. However, Groupe Sfpi is 2.08 times less risky than Maat Pharma. It trades about 0.17 of its potential returns per unit of risk. Maat Pharma SA is currently generating about -0.12 per unit of risk. If you would invest  198.00  in Groupe Sfpi on April 24, 2025 and sell it today you would earn a total of  39.00  from holding Groupe Sfpi or generate 19.7% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy98.44%
ValuesDaily Returns

Groupe Sfpi  vs.  Maat Pharma SA

 Performance 
       Timeline  
Groupe Sfpi 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Groupe Sfpi are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Groupe Sfpi sustained solid returns over the last few months and may actually be approaching a breakup point.
Maat Pharma SA 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Maat Pharma SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in August 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Groupe Sfpi and Maat Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Groupe Sfpi and Maat Pharma

The main advantage of trading using opposite Groupe Sfpi and Maat Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Groupe Sfpi position performs unexpectedly, Maat Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maat Pharma will offset losses from the drop in Maat Pharma's long position.
The idea behind Groupe Sfpi and Maat Pharma SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Stocks Directory
Find actively traded stocks across global markets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges